Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 684-688

  Becher, Burkhard ^a   Blain, Manon ^a   Giacomini, Paul S ^a   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADULT; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL POLARITY; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SOLUBILITY; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033556352     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
2. Olsson, T. 1995. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 45 (Suppl. 6):S11.
3. Schulze-Koops, H., P. E. Lipsky, A. F. Kavanaugh, and L. S. Davis. 1995. Elevated Th1 - or Th0-like cytokine mRN A in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J. Immunol. 155:5029.
4. Renno, T., M. Krakowski, C. Piccirillo, J. Y. Lin, and T. Owens. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J. Immunol. 154:944.
5. Khoruts, A., S. D. Miller, and M. K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient supressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155:5011.
6. Conboy, I. M., R. H. DeKruyff, K. M. Tate, Z. A. Cao, T. A. Moore. D. T. Umetsu, and P. P. Jones. 1997. Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J. Exp. Med. 185:439.
7. Austrup, F., D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385:81.
8. Cua, D. J., D. R. Hinton, and S. A. Stohlman. 1995. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155:4052.
9. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
10. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
11. Korner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in CNS autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.
12. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2840.
13. Segal, B. M., B. K. Dwyer, and E. M. Shevach. 1998. An Interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:537.
14. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
15. Ma, X., M. Aste-Amezaga, and G. Trinchieri. 1996. Regulation of interleukin-12 production. Ann. NY Acad. Sci. 795:13.
16. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16:383.
17. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heuffer, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
18. Becher, B., V. Dodelet, V. Fedorowicz, and J. P. Antel. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539.
19. Korner, H., F. A. Lemckert, G. Chaudhri, S. Etteldorf, and J. D. Sedgwick. 1997. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol. 27:1973.
20. Klinkert, W. E., K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, and H. Wekerle. 1997. TNF-α receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:163.
21. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, M. B. Widmer, and C. M. Blosch. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
22. Andersson, P. B., E. Waubant, and D. E. Goodkin. 1997 How should we procede with disease-modifying treatments for multiple sclerosis. Lancet 349:586.
23. Becher, B., and J. P. Antel. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18:1.
24. D'Souza, S., K. Alinauskas, E. McCrea, C. Goodyer, and J. P. Antel. 1995. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:7293.
25. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
26. Rieckmann, P., M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Luer, A. Helwig, and S. Poser. 1995. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:82.
27. Drulovic, J., M. Mostarica-Stojkovic, Z. Levic, N. Stojsavljevic, V. Pravica, and S. Mesaros. 1997. Interleukin-12 and tumor necrosis factor-α levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol. Sci. 147:145.
28. Nicoletti, F., F. Patti, C. Cocuzza, P. Zaccone, A. Nicoletti, R. Di Marco, and A. Reggio. 1996. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 70:87.
29. Korner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in CNS autoimmune inflammation denned by gene targeting. J. Exp. Med. 186:1585.